Smith & Nephew (SNN) Cost of Revenue (2009 - 2024)
Smith & Nephew (SNN) posted quarterly Cost of Revenue of $853.0 million for Q4 2024, up 2.03% year-on-year from $836.0 million in Q1 2024, and up 2.03% on a QoQ basis from $836.0 million in Q4 2023.
Smith & Nephew (SNN) Cost of Revenue (2009 - 2024) Analysis & Trends
Smith & Nephew (SNN) has reported Cost of Revenue for 16 consecutive years, with $853.0 million the latest figure, recorded in Q4 2024.
- Quarterly Cost of Revenue rose 2.03% year-over-year to $853.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $3.3 billion (up 6.76% YoY) and the FY2025 annual result came in at $2.0 billion, up 11.79% from the prior year.
- Cost of Revenue rose to $853.0 million in Q4 2024 per SNN's latest filing, from $836.0 million in the prior quarter.
- Over the last five years, Cost of Revenue for SNN reached as high as $853.0 million in Q4 2024 and fell as low as $646.0 million in Q4 2020.
- A 5-year average of $782.8 million and a median of $806.0 million in 2021 frame the typical range for Cost of Revenue.
- Annual changes were most pronounced in 2020 — Cost of Revenue tumbled 51.72% — and 2021, when it climbed 24.77%.
- Year by year, Cost of Revenue stood at $646.0 million in 2020, then advanced by 24.77% to $806.0 million in 2021, then slipped by 4.09% to $773.0 million in 2022, then climbed by 8.15% to $836.0 million in 2023, then advanced by 2.03% to $853.0 million in 2024.
- According to Business Quant data, Cost of Revenue over the past three periods registered $853.0 million, $836.0 million, and $773.0 million for Q4 2024, Q4 2023, and Q4 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 4.89 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 2.21 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 12.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 362.60 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 441.60 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 481.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 2.51 Bn |
| 10 | Steris | 21.47 Bn | 21.03 Bn | 697.10 Mn | 891.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 853.00 Mn |
| Dec 31, 2024 | 853.00 Mn |
| Dec 31, 2023 | 836.00 Mn |
| Dec 31, 2023 | 836.00 Mn |
| Dec 31, 2022 | 773.00 Mn |
| Dec 31, 2022 | 773.00 Mn |
| Dec 31, 2021 | 806.00 Mn |
| Dec 31, 2021 | 806.00 Mn |
| Dec 31, 2020 | 646.00 Mn |
| Dec 31, 2020 | 646.00 Mn |
| Dec 31, 2019 | 1.34 Bn |
| Dec 31, 2019 | 1.34 Bn |
| Dec 31, 2018 | 1.30 Bn |
| Dec 31, 2018 | 1.30 Bn |
| Dec 31, 2017 | 1.25 Bn |
| Dec 31, 2017 | 1.25 Bn |
| Dec 31, 2016 | 1.27 Bn |
| Dec 31, 2016 | 1.27 Bn |
| Dec 31, 2015 | 1.14 Bn |
| Dec 31, 2015 | 1.14 Bn |